Cargando…
Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis
Rationale: Although mesenchymal stem cell (MSC) transplantation has been proved to be an effective therapeutic approach to treat experimental Sjögren's syndrome (SS), the detailed underlying mechanisms remains unknown. IL-27 has diverse influences on the regulation of T cell differentiation and...
Autores principales: | Yao, Genhong, Qi, Jingjing, Liang, Jun, Shi, Bingyu, Chen, Weiwei, Li, Wenchao, Tang, Xiaojun, Wang, Dandan, Lu, Liwei, Chen, Wanjun, Shi, Songtao, Hou, Yayi, Sun, Lingyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857067/ https://www.ncbi.nlm.nih.gov/pubmed/31754394 http://dx.doi.org/10.7150/thno.37351 |
Ejemplares similares
-
Mesenchymal stem cell transplantation ameliorates Sjögren’s syndrome via suppressing IL-12 production by dendritic cells
por: Shi, Bingyu, et al.
Publicado: (2018) -
IL-27 Regulated CD4(+)IL-10(+) T Cells in Experimental Sjögren Syndrome
por: Qi, Jingjing, et al.
Publicado: (2020) -
Umbilical cord mesenchymal stem cells alleviate Sjögren’s syndrome and related pulmonary inflammation through regulating Vγ4(+) IL-17(+) T cells
por: Cong, Yan, et al.
Publicado: (2022) -
Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs
por: Yao, Genhong, et al.
Publicado: (2022) -
Mesenchymal stem cells inhibited the differentiation of MDSCs via COX2/PGE2 in experimental sialadenitis
por: Qi, Jingjing, et al.
Publicado: (2020)